Non-surgical treatment of osteoarthritis-related pain in the elderly

Current Reviews in Musculoskeletal Medicine

Volumn 4, Issue 3, 2011, Pages 113-122

  Mushtaq, Saulat ^c   Choudhary, Rabeea ^b   Scanzello, Carla R ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEW MEXICO HOSPITAL   (United States)

^c Division of Rheumatology   (United States)

Author keywords

Arthritis; Efficacy; Elderly; Osteoarthritis; Pain management; Rheumatology; Safety; Toxicity; Treatment

Indexed keywords

CAPSAICIN; CELECOXIB; CHONDROITIN; CORTICOSTEROID; DICLOFENAC; DIMETHYL SULFONE; DULOXETINE; EUFLEXXA; GINGER EXTRACT; GLUCOSAMINE; HYALURONIC ACID; HYALURONIC ACID DERIVATIVE; LIDOCAINE; MORPHINE; NAPROXEN; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OXYCODONE; PARACETAMOL; PIASCLEDINE; PLACEBO; S ADENOSYLMETHIONINE; TRAMADOL; UNCLASSIFIED DRUG;

AEROBIC EXERCISE; ARTHRALGIA; ARTICLE; BRACE; CARDIOVASCULAR DISEASE; CONSERVATIVE TREATMENT; CONSTIPATION; DIZZINESS; DRUG BLOOD LEVEL; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; ELDERLY CARE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL TOXICITY; HEADACHE; HUMAN; INJECTION SITE REACTION; INJECTION SITE SWELLING; INJECTION SITE WARMTH; KNEE OSTEOARTHRITIS; LIVER TOXICITY; LOW BACK PAIN; MUSCULOSKELETAL PAIN; NAUSEA; NEPHROTOXICITY; NONHUMAN; ORTHOPEDIC SHOE; ORTHOTICS; OSTEOARTHRITIS; PATIENT COMPLIANCE; PHYSIOTHERAPY; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; SEIZURE; SKIN BURNING SENSATION; SKIN IRRITATION; SOCIAL SUPPORT; STOMACH HEMORRHAGE; STOMACH PERFORATION; STOMACH ULCER; TREATMENT DURATION; WEIGHT REDUCTION; XEROSTOMIA;

EID: 80054981838     PISSN: 1935973X     EISSN: 19359748     Source Type: Journal    
DOI: 10.1007/s12178-011-9084-9     Document Type: Article

References (88)

1. Felson DT, Lawrence RC, Dieppe PA, et al. Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med. 2000;133:635-46.
2. Mili F, Helmick CG, Moriarty DG. Health related quality of life among adults reporting arthritis: analysis of data from the behavioral risk factor surveillance system, US, 1996-99. J Rheumatol. 2003;30:160-6. (Pubitemid 36077789)
3. Guccione AA, Felson DT, Anderson JJ, et al. The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health. 1994;84:351-8. (Pubitemid 24107816)
4. Buckwalter JA, Saltzman C, Brown T: The impact of osteoarthritis: implications for research. Clin Orthop Relat Res 2004;(427 Suppl):S6-15. (Pubitemid 39362794)
5. Tan AL, Grainger AJ, Tanner SF, et al. High-resolution magnetic resonance imaging for the assessment of hand osteoarthritis. Arthritis Rheum. 2005;52:2355-65. (Pubitemid 41117420)
6. Burr DB, Radin EL. Microfractures and microcracks in subchondral bone: are they relevant to osteoarthrosis? Rheum Dis Clin North Am. 2003;29:675-85. (Pubitemid 37296765)
7. Hawker G: Experiencing painful osteoarthritis: what have we learned from listening? Curr Opin Rheumatol 2009;21:507. An interesting review of our current understanding that osteoarthritis pain is multidimensional, reflecting the influence of biological, psychological and social factors. Suggest that discussion of OA pain should include attention to words people use to describe pain to help with mechanism and evidence based treatment.
8. Iwasa H, Yoshida Y, Kumagai S, et al. Depression status as a reliable predictor of functional decline among Japanese community-dwelling older adults: a 12-year population-based prospective cohort study. Int J Geriatr Psychiatry. 2009;24:1192-200
9. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum 2000;43:1905-15.
10. Zhang W, Nuki G, Moskowitz RW, et al.: OARSI recommendations for the management of hip and knee osteoarthritis: Part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage 2010;18:476-499. A good synthesis of cumulative evidence for management of hip and knee OA published up to 2009; includes evidence on pharmacologic, non-pharmacologic agents and surgical options. Of the three published treatment guidelines referenced in this review, the OARSI guidelines are the most recently updated.
11. Kerrigan DC, Lelas JL, Goggins J, et al. Effectiveness of a lateralwedge insole on knee varus torque in patients with knee osteoarthritis. Arch Phys Med Rehabil. 2002;83:889-93. (Pubitemid 34747568)
12. Maillefert JF, Hudry C, Baron G, et al. Laterally elevated wedged insoles in the treatment of medial knee osteoarthritis: a prospective randomized controlled study. Osteoarthr Cartil. 2001;9:738-45. (Pubitemid 33076765)
13. Pham T, Maillefert JF, Hudry C, et al. Laterally elevated wedged insoles in the treatment of medial knee osteoarthritis: a two-year prospective randomized controlled study. Osteoarthr Cartil. 2004;12:46-55. (Pubitemid 38111550)
14. Butler RJ, Barrios JA, Royer T. Effect of laterally wedged foot orthoses on rearfoot and hip mechanics in patients with medial knee osteoarthritis. Prosthet Orthot Int. 2009;33:107-16.
15. Shimada S, Kobayashi S, Wada M, et al. Effects of disease severity on response to lateral wedged shoe insole for medial compartment knee osteoarthritis. Arch Phys Med Rehabil. 2006;87:1436-41. (Pubitemid 44647177)
16. Baker K, Goggins J, Xie H, et al. A randomized crossover trial of a wedged insole for treatment of knee osteoarthritis. Arthritis Rheum. 2007;56:1198-203. (Pubitemid 46608644)
17. Hinman RS, Payne C, Metcalf BR, et al. Lateral wedges in knee osteoarthritis: what are their immediate clinical and biomechanical effects and can these predict a three-month clinical outcome? Arthrit Care Res. 2008;59:408-15. (Pubitemid 351399211)
18. Shakoor N, Block JA. Walking barefoot decreases loading on the lower extremity joints in knee osteoarthritis. Arthritis Rheum. 2006;54:2923-7. (Pubitemid 44497771)
19. Shakoor N, Sengupta M, Foucher KC, et al.: Effects of common footwear on joint loading in osteoarthritis of the knee. Arthrit Care Res 2010;62:917-923. Nicely designed study demonstrating that everyday shoes like clogs and stability shoes increase joint load compared with bare foot walking.
20. Shakoor N, Lidtke RH, Sengupta M, et al. Effects of specialized footwear on joint loads in osteoarthritis of the knee. Arthrit Care Res. 2008;59:1214-20.
21. Kirkley A, Webster-Bogaert S, et al. The effect of bracing on varus gonarthrosis. J Bone Joint Surg Am. 1999;81:539-48. (Pubitemid 29211595)
22. Sharma L, Pai YC, Holtkamp K, et al. Is knee joint proprioception worse in the arthritic knee versus the unaffected knee in unilateral knee osteoarthritis? Arthritis Rheum. 1997;40:1518-25.
23. Richards JD, Sanchez-Ballester J, Jones RK, et al. A comparison of knee braces during walking for the treatment of osteoarthritis of the medial compartment of the knee. J Bone Joint Surg Br. 2005;87:937-9. (Pubitemid 40984262)
24. Chuang SH, Huang MH, Chen TW, et al. Effect of knee sleeve on static and dynamic balance in patients with knee osteoarthritis. Kaohsiung J Med Sci. 2007;23:405-11.
25. Brouwer RW, van Raaij TM, Verhaar JA, et al. Brace treatment for osteoarthritis of the knee: a prospective randomized multi-centre trial. Osteoarthr Cartil. 2006;14:777-83. (Pubitemid 43986362)
26. Brouwer GM, Tol AWV, Bergink AP, et al. Association between valgus and varus alignment and the development and progression of radiographic osteoarthritis of the knee. Arthritis Rheum. 2007;56:1204-11. (Pubitemid 46608645)
27. Warden SJ, Hinman RS, Watson MA, et al.: Patellar taping and bracing for the treatment of chronic knee pain: A systematic review and meta-analysis. Arthrit Care Res 2008;59:73-83. Evaluation of 13 trials investigating the value of taping and bracing, concluding that medially directed force on the patella produces significant reduction in pain in varus malalignment. (Pubitemid 351171881)
28. Hunter DJ, Harvey W, Gross KD, et al: A randomized trial of patellofemoral bracing for treatment of patellofemoral osteoarthritis. Osteoarthritis Cartilage 2011, (Epub ahead of print) doi:10.1016/j.joca.2010.12. 010. A recent and well designed trial of patellar bracing in patients with patellofemoral OA. The authors did not demonstrate a significant effect on pain with one type of commercially available brace. However, whether this specific brace sufficiently modified patellar tracking was not evaluated.
29. Slemenda C, Brandt KD, Heilman DK, et al. Quadriceps weakness and osteoarthritis of the knee. Ann Intern Med. 1997;127:97-104. (Pubitemid 27337392)
30. Van Baar ME, Assendelft WJ, Dekker J, et al. Effectiveness of exercise therapy in patients with osteoarthritis of the hip or knee: a systematic review of randomized clinical trials. Arthritis Rheum. 1999;42:1361-9. (Pubitemid 30265593)
31. Segal NA, Torner JC, Felson D, et al. Effect of thigh strength on incident radiographic and symptomatic knee osteoarthritis in a longitudinal cohort. Arthrit Care Res. 2009;61:1210-17.
32. Zhao D, Banks SA, Mitchell KH, et al. Correlation between the knee adduction torque and medial contact force for a variety of gait patterns. J Orthop Res. 2007;25:789-97. (Pubitemid 46831888)
33. Lim B, Hinman RS, Wrigley TV, et al. Does knee malalignment mediate the effects of quadriceps strengthening on knee adduction moment, pain, and function in medial knee osteoarthritis? A randomized controlled trial. Arthrit Care Res. 2008;59:943-51. (Pubitemid 351990990)
34. Bennell KL, Hunt MA, Wrigley TV, et al. Hip strengthening reduces symptoms but not knee load in people with medial knee osteoarthritis and varus malalignment: a randomised controlled trial. Osteoarthr Cartil. 2010;18:621-8.
35. Thorp LE, Wimmer MA, Foucher KC, et al. The biomechanical effects of focused muscle training on medial knee loads in OA of the knee: a pilot, proof of concept study. J Musculoskelet Neuronal Interact. 2010;10:166-73.
36. Jansen MJ, Viechtbauer W, Lenssen AF, et al.: Strength training alone, exercise therapy alone, and exercise therapy with passive manual mobilization each reduce pain and disability in people with knee osteoarthritis: a systematic review. J Physiother 2011;57:11-20. Exercise therapy with manual mobilization appears superior to strength training or exercise therapy alone even though all three modalities improve pain and physical function.
37. Mangami I, Cesari M, Kritchevky SB et al. Physcial exercise and comorbidity. Results from the Fitness and Arthritis in Seniors Trial (FAST). 2006;18: 374-80.
38. Graham GG, Scott KF. Mechanism of action of paracetamol. Am J Ther. 2005;12:46-55. (Pubitemid 40516046)
39. Jordan KM, Arden NK, Doherty M, et al. EULAR Recommendations 2003: an evidence base approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis. 2003;62:1145-55. (Pubitemid 37500619)
40. Towheed TE, Maxwell L, Judd MG, et al.: Acetaminophen for osteoarthritis. Cochrane Database Syst Rev 2006;CD004257.
41. Chan AT, Manson JE, Albert CM, et al. Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events. Circulation. 2006;113:1578-87. (Pubitemid 43739417)
42. Rahme E, Barkun A, Nedjar H, et al.: Hospitalizations for upper and lower GI events associated with traditional NSAIDs and acetaminophen among the elderly in Quebec, Canada. Am J Gastroenterol 2008;103:872-882. Combination therapy of acetaminophen and NSAID may compound GI toxicity. (Pubitemid 351501121)
43. Curhan GC, Knight EL, Rosner B, et al. Lifetime nonnarcotic analgesic use and decline in renal function in women. Arch Intern Med. 2004;164:1519-24. (Pubitemid 38970471)
44. Bjordal JM, Klovning A, Ljunggren AE, et al. Short-term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: a meta-analysis of randomised placebo-controlled trials. Eur J Pain. 2007;11:125-38. (Pubitemid 44829965)
45. McGettigan P, Henry D. Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. JAMA. 2006;296:1633-44. (Pubitemid 44511610)
46. Geba GP, Weaver AL, Polis AB, Dixon ME, et al. Vioxx, Acetaminophen, Celecoxib Trial (VACT) Group: efficacy of rofecoxib, celecoxib and acetaminophen in osteoarthritis of the knee: a randomized trial. JAMA. 2002;287:64-71. (Pubitemid 34251677)
47. Rahme E, Barkun AN, Toubouti Y, et al. Do proton-pump inhibitors confer additional gastrointestinal protection in patients given celecoxib? Arthrit Care Res. 2007;57:748-55. (Pubitemid 46932079)
48. Barkin RL. Extended-release tramadol (ULTRAM ER): a pharmacotherapeutic, pharmacokinetic, and pharmacodynamic focus on effectiveness and safety in patients with chronic/persistent pain. Am J Ther. 2008;15:157-66. (Pubitemid 351450780)
49. Cepeda MS, Camargo F, Zea C, et al. Tramadol for osteoarthritis: a systematic review and metaanalysis. J Rheumatol. 2007;34:543-55 (Pubitemid 46364009)
50. Vorsanger G, Xiang J, Jordan D, et al.: Post hoc analysis of a randomized, double-blind, placebo-controlled efficacy and tolerability study of tramadol extended release for the treatment of osteoarthritis pain in geriatric patients. Clin Ther 2007;(29 Suppl):2520-2535. (Pubitemid 350299463)
51. Sansone RA, Sansone LA. Tramadol: Seizures, serotonin syndrome, and coadministered antidepressants. Psychiatry (Edgmont). 2009;6:17-21.
52. Nuesch E, Rutjes AW, Husni E, et al.: Oral or transdermal opioids for osteoarthritis of the knee or hip. Cochrane Database Syst Rev 2009;4:CD003115. As there are numerous small studies on opioid agents with a myriad of limitations, this updated systemic review is helpful in synthesizing the available evidence.
53. Furlan AD, Sandoval JA, Mailis-Gagnon A, et al. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ. 2006;174:1589-94. (Pubitemid 43829515)
54. Sullivan MD, Bentley S, Fan M-Y, Gardner G. A single-blind, placebo run-in study of duloxetine for activity-limiting osteoarthritis pain. J Pain. 2009;10:208-13.
55. Chandran P, Pai M, Blomme EA, et al. Pharmacological modulation of movement-evoked pain in a rat model of osteoarthritis. Eur J Pharmacol. 2009;613:39-45.
56. Chappell AS, Desaiah D, Liu-Seifert H, et al.: A double-blind, randomized, placebo-controlled study of the efficacy and safety of duloxetine for the treatment of chronic pain due to osteoarthritis of the knee. Pain Practice 2010;11: 33-41. This is the latest publication on the results from a 13 week RCT of duloxetine for the treatment of knee OA pain. This agent is one of the most recent (November 2010) to receive FDA approval for the treatment of OA-related pain.
57. Brunton S, Wang F, Edwards SB, et al. Profile of adverse events with duloxetine treatment. Drug Saf. 2010;33:393-407.
58. Lin J, Zhang W, Jones A. Efficacy of topical non-steroidal antiinflammatory drugs in the treatment of osteoarthritis: metaanalysis of randomised controlled trials. BMJ. 2004;329:324.
59. Biswal S, Medhi B, Pandhi P. Longterm efficacy of topical nonsteroidal anti-inflammatory drugs in knee osteoarthritis: metaanalysis of randomized placebo controlled clinical trials. J Rheumatol. 2006;33:1841-4. (Pubitemid 44373220)
60. Altman RD, Dreiser RL, Fisher CL, et al.: Diclofenac sodium gel in patients with primary hand osteoarthritis: a randomized, double-blind, placebo-controlled trial. J Rheumatol 2009;36:1991-1999. An RCT on one of the more recently FDA approved topical agents used to treat OA. This study focuses specifically on hand OA, which is an often overlooked source of pain and disability in the elderly.
61. Simon LS, Grierson LM, Naseer Z, et al. Efficacy and safety of topical diclofenac containing dimethyl sulfoxide (DMSO) compared with those of topical placebo, DMSO vehicle and oral diclofenac for knee osteoarthritis. Pain. 2009;143:238-45.
62. Gammaitoni AR, Galer BS, Onawola R, et al.: Lidocaine patch 5% and its positive impact on pain qualities in osteoarthritis: results of a pilot 2-week, open-label study using the neuropathic pain scale. Curr Med Res Opin 2004;(20 Suppl 2): S13-9. (Pubitemid 40179646)
63. Burch F, Codding C, Patel N, et al. Lidocaine patch 5% improves pain, stiffness, and physical function in osteoarthritis pain patients: a prospective, multicenter, open-label effectiveness trial. Osteoarthr Cartil. 2004;12:253-5. (Pubitemid 38248075)
64. Bellamy N, Campbell J, Robinson V, et al. Intraarticular corticosteroid for treatment of osteoarthritis of the knee. Cochrane Database Syst Rev. 2006;2:CD005328.
65. Micu MC, Bogdan GD, Fodor D. Steroid injection for hip osteoarthritis: efficacy under ultrasound guidance. Rheumatology (Oxford). 2010;49:1490-4.
66. Chevalier X, Jerosch J, Goupille P, et al. Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised,multicentre, doubleblind, placebo controlled trial. Ann Rheum Dis. 2010;69:113-19.
67. Miltner O, Schneider U, Siebert CH, et al. Efficacy of intraarticular hyaluronic acid in patients with osteoarthritis: a prospective clinical trial. Osteoarthr Cartil. 2002;10:680-6. (Pubitemid 34993956)
68. Dougados M, Nguyen M, Listrat V, et al. High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year placebo-controlled trial. Osteoarthr Cartil. 1993;1:97-103.
69. Bellamy N, Campbell J, Robinson V, et al.: Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2006;CD005321.
70. Lussier A, Cividino AA, McFarlane CA, et al. Viscosupplementation with hylan for the treatment of osteoarthritis: findings from clinical practice in Canada. J Rheumatol. 1996;23:1579-85. (Pubitemid 26290585)
71. Lohmander LS, Dalen N, Englund G, et al. Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: a randomized double blind, placebo controlled multicentre trial. Hyaluronan Multicentre Trial Group. Ann Rheum Dis. 1996;55:424-31. (Pubitemid 26249016)
72. Brander VA, Gomberawalla A, Chambers M, Bowen M, Nuber G. Efficacy and safety of hylan G-F for symptomatic glenohumeral osteoarthritis: a prospective, pilot study. PMR. 2010;2:259-67.
73. Miglore A, Massafra U, Bizzi E, et al. Comparative, double-blind, controlled study of intra-articular hyaluronic acid (Hyalubrix) injections versus local anesthetic in osteoarthritis of the hip. Arthritis Res Ther. 2009;11:R183.
74. Mandl LA, Hotchkiss RN, Adler RS, et al. Injectable hyaluronan for the treatment of carpometacarpal osteoarthritis: open label pilot trial. Curr Med Res Opin. 2009;15:2103-8.
75. Disla E, Infante R, Fahmy A, et al. Recurrent acute calcium pyrophosphate dihydrate arthritis following intraarticular hyaluronate injection. Arthritis Rheum. 1999;42:1302-3. (Pubitemid 29268974)
76. Luzar MJ, Altawil B. Pseudogout following intraarticular injection of sodium hyaluronate. Arthritis Rheum. 1998;41:939-40.
77. Ernst E. Complementary or alternative therapies for osteoarthritis. Nat Clin Pract Rheumatol. 2006;2:74-80. (Pubitemid 43239206)
78. Clegg DO, Reda DJ, Harris CL, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med. 2006;354:795-808. (Pubitemid 43290918)
79. Herrero-Beaumont G, Ivorra JA, Del Carmen Trabado M. Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator. Arthritis Rheum. 2007;56:555-67.
80. Biggee BA, Blinn CM, McAlindon TE, et al. Low levels of human serum glucosamine after ingestion of glucosamine sulphate relative to capability for peripheral effectiveness. Ann Rheum Dis. 2006;65:222-6. (Pubitemid 43131997)
81. Sun BH, Wu CW, Kalunian KC. New developments in osteoarthritis. Rheum Dis Clin North Am. 2007;33:135-48. (Pubitemid 46400359)
82. Towheed TE, Maxwell L, Anastassiades TP, et al.: Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev 2005;CD002946.
83. Sawitzke AD, Shi H, Finco MF, et al.: Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2- year results from GAIT. Ann Rheum Dis 2010;69:1459-1464. The two-year outcomes from the GAIT trial, the large, NIH funded study evaluating Glucosamine and Chondroitin supplements on knee OA. Glucosamine, Chondroitin or the combination of these did not reduce OA pain significantly.
84. Goekoop RJ, Kloppenburg M, Kroon HM, et al. Low innate production of interleukin-1â and interleukin-6 is associated with the absence of osteoarthritis in old age. Osteoarthr Cartil. 2010;18:942-7.
85. Chevalier X, Goupille P, Beaulieu AD, et al.: Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study. Arthrit Care Res 2009;61:344-52. A 12-week RCT of this agent, originally developed to treat Rheumatoid Arthritis. In this study, anakinra was used as a single injection intra-articularly, and failed to show improvement in OA pain. Although results were disappointing, IL- 1 blockade using longer-acting agents and different regimens are currently being studied, and may become available in the future.
86. Watson JJ, Allen SJ, Dawbarn D. Targeting nerve growth factor in pain: what is the therapeutic potential? BioDrugs. 2008;22:349-59
87. ™, a novel agent targeted nerve-growth factor, produced significant pain reduction compared with placebo but caused headaches, URIs and hypoesthesias. Although initially promising,recent concerns that this agent may have hastened the need for joint replacement in study patients resulted in the discontinuation of this trial.
88. Dekker J, van Dijk GM, Veenhof C: Risk factors for functional decline in osteoarthritis of the hip or knee. Curr Opin Rheumatol 2009;21:520-524. A useful review of the risk factors for functional decline in the elderly, which include physical impairments from osteoarthritis (pain, stiffness, reduced muscle strength, joint instability, proprioceptive inaccuracy, poor balance and impaired range of motion), as well as cognitive and visual impairments, comorbidities, psychological and social factors, health behaviors and socio-demographic factors. This can be useful for patients and physicians and encourages the approach of treating the "whole patient", not just the osteoarthritis.